Clover Health publishes supplemental Q&A re Q4 2025 earnings

CLOVER HEALTH INVESTMENTS, CORP. /DE

Filed under Item 7.01; responses to frequently asked questions from shareholders.
Document is furnished as Exhibit 99.1; available on investor relations page.
No new financial results or guidance disclosed in the 8-K filing body.

item 7.01 item 9.01

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-26-000069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.